{"meta":{"query_hash":"78a46fbda7ab","filters":{"venue":"Drug Research"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/78a46fbda7ab","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Research"},"results":[{"id":"W2891396588","doi":"10.1055/a-0677-2944","title":"The Association between Genetic Polymorphisms and Simvastatin-Induced Myopathy: A Narrative Synthesis of Evidence","year":2018,"lang":"en","type":"article","venue":"Drug Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Beijing Municipal Administration of Hospitals; National Natural Science Foundation of China","keywords":"SLCO1B1; Myopathy; Simvastatin; Genetics; Genetic association; SNP; Allele; Population; Medicine; Genotype; Pharmacogenetics; Bioinformatics; Internal medicine; Biology; Single-nucleotide polymorphism; Gene","score_opus":0.1258101092280829,"score_gpt":0.4001344501623763,"score_spread":0.2743243409342934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891396588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926013,0.0013786606,0.00002136174,0.0047377297,0.000047530433,0.00062796345,0.000004882601,0.000011486592,0.0005690887],"genre_scores_gemma":[0.99792546,0.0004973756,0.0001717579,0.000029160536,0.00063491636,0.00007039653,8.759545e-7,0.000014356873,0.0006556835],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969916,0.0008271674,0.00023750187,0.00022883929,0.0013423694,0.00037253837],"domain_scores_gemma":[0.9963489,0.0021653848,0.00008924577,0.00042621233,0.0008279974,0.00014221281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006617429,0.00007777537,0.0002595423,0.0001012285,0.00043753505,0.00003703602,0.00012474865,0.00006517147,0.000019422601],"category_scores_gemma":[0.0048760567,0.00004578896,0.000074779346,0.00040511685,0.00021066143,0.000055011875,0.00009266321,0.00028373708,0.000023778657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002878073,0.00007906269,0.2223799,0.00033287963,0.0007431903,0.000024157755,0.0191739,2.3834112e-7,0.018039914,0.00017702841,0.002423423,0.7363385],"study_design_scores_gemma":[0.0005637993,0.00072889205,0.88963115,0.0005912302,0.0001229484,0.000009916342,0.0048990385,0.00010352852,0.10044599,0.0003906092,0.0023928434,0.00012007225],"about_ca_topic_score_codex":0.0011438852,"about_ca_topic_score_gemma":0.00009888254,"teacher_disagreement_score":0.73621845,"about_ca_system_score_codex":0.00017079287,"about_ca_system_score_gemma":0.0003747549,"threshold_uncertainty_score":0.5837447},"labels":[],"label_agreement":null},{"id":"W2915821260","doi":"10.1055/a-0846-3071","title":"Vasoactive Agents for the Management of Variceal Bleeding: A Mixed Treatment Comparison Network Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials","year":2019,"lang":"en","type":"article","venue":"Drug Research","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia","keywords":"Terlipressin; Medicine; Vasopressin; Octreotide; Randomized controlled trial; Internal medicine; Meta-analysis; Adverse effect; Hemostasis; Somatostatin; Anesthesia; Cirrhosis; Hepatorenal syndrome","score_opus":0.5407680509453634,"score_gpt":0.5641070094091865,"score_spread":0.023338958463823056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915821260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745444,0.0024759015,0.009734471,0.00051558303,0.00021055857,0.011735223,0.00029495743,0.000011066059,0.0004778531],"genre_scores_gemma":[0.9968879,0.0010807691,0.0004533179,0.000010250462,0.00011505673,0.00043106364,0.0003161876,0.000008876538,0.0006965297],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930636,0.0039648176,0.0014428578,0.0003762615,0.00089498475,0.00025742105],"domain_scores_gemma":[0.9839684,0.014682854,0.00049159833,0.00038616775,0.0003524763,0.000118545824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025167761,0.0001424563,0.0040491843,0.00053562643,0.00008666733,0.00002741233,0.00012500747,0.00006949525,0.0003328011],"category_scores_gemma":[0.0000715043,0.000075317905,0.0042626043,0.0015032487,0.00017638956,0.0000426599,0.000040949293,0.00013127664,0.000002242406],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32181254,0.00050252216,0.0031391203,0.00008656009,0.6719453,0.0000028229656,0.0005936363,0.0010770706,0.000007150426,0.00040454295,0.000045577923,0.00038319587],"study_design_scores_gemma":[0.22718212,0.00035812482,0.007048634,0.0000075316216,0.7352307,6.89811e-8,0.0005263634,0.02927574,0.00023522778,0.00007364968,0.000016896927,0.00004496914],"about_ca_topic_score_codex":0.0006396049,"about_ca_topic_score_gemma":0.00006233066,"teacher_disagreement_score":0.094630405,"about_ca_system_score_codex":0.000043158554,"about_ca_system_score_gemma":0.000078984995,"threshold_uncertainty_score":0.8722694},"labels":[],"label_agreement":null},{"id":"W2981569509","doi":"10.1055/a-1025-0119","title":"A Pharmacokinetic Evaluation of Dabigatran Etexilate, Total Dabigatran, and Unconjugated Dabigatran Following the Administration of Dabigatran Etexilate Mesylate Capsules in Healthy Male and Female Subjects","year":2019,"lang":"en","type":"article","venue":"Drug Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Dabigatran; Pharmacokinetics; Medicine; Cmax; Pharmacology; Mesylate; Bioequivalence; Dosing; Tolerability; Anesthesia; Adverse effect; Internal medicine; Warfarin; Chemistry; Atrial fibrillation","score_opus":0.13494730984153305,"score_gpt":0.4471364936537274,"score_spread":0.3121891838121943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981569509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944646,0.0017138683,0.0000029071616,0.0033224726,0.00020723382,0.0031276518,0.000021560025,0.000029491759,0.0021283503],"genre_scores_gemma":[0.99854094,0.0004159049,0.000101660735,0.000045899153,0.00012932802,0.000025653439,0.000081429236,0.000044512937,0.0006146559],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9951944,0.0009436276,0.00095389265,0.00060839154,0.00170881,0.000590913],"domain_scores_gemma":[0.9980497,0.00063842867,0.00022948573,0.0004921342,0.0003722095,0.00021805012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066106287,0.0002918546,0.00070088136,0.00054301106,0.00017285146,0.000062581974,0.00018716356,0.00015419525,0.00016356562],"category_scores_gemma":[0.0003070667,0.0002297586,0.00017985124,0.0010355128,0.00035588272,0.0003158294,0.00010684915,0.0005474759,0.00001057586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066921813,0.0001469494,0.4165291,0.0026480476,0.00045218816,0.00009440438,0.008129496,0.0008352135,0.54405046,0.0006752897,0.00007238565,0.019674333],"study_design_scores_gemma":[0.022162678,0.0021122557,0.77507997,0.0010519307,0.00080491323,0.0001681855,0.0055729155,0.026231522,0.16503067,0.00084161834,0.0003126346,0.0006307274],"about_ca_topic_score_codex":0.00050173944,"about_ca_topic_score_gemma":0.0003618512,"teacher_disagreement_score":0.37901977,"about_ca_system_score_codex":0.00009998348,"about_ca_system_score_gemma":0.0004330388,"threshold_uncertainty_score":0.93692845},"labels":[],"label_agreement":null},{"id":"W3031151994","doi":"10.1055/a-1170-3083","title":"The Pharmacokinetics of Fluticasone Furoate Given Intranasally in Healthy Subjects Using an Ultra-Sensitive Analytical Assay","year":2020,"lang":"en","type":"article","venue":"Drug Research","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Fluticasone propionate; Pharmacokinetics; Cmax; Nasal administration; Crossover study; Fluticasone; Pharmacology; Bioequivalence; Medicine; Mometasone furoate; Chemistry; Chromatography; Corticosteroid; Internal medicine","score_opus":0.25758524397558386,"score_gpt":0.5032295597841934,"score_spread":0.24564431580860951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031151994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95927346,0.00065580074,0.0028831034,0.019429682,0.00008758713,0.000510288,0.000079575526,0.0000829958,0.01699751],"genre_scores_gemma":[0.9968235,0.00031431403,0.0019837865,0.00044430248,0.00029512416,0.000008672909,0.0000064192322,0.000053111024,0.00007076462],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934565,0.0025197533,0.0007531931,0.0006461217,0.001439578,0.0011848691],"domain_scores_gemma":[0.990206,0.00784937,0.000094271054,0.0004969716,0.000545808,0.0008075609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007368941,0.00023305575,0.00049393554,0.0001420875,0.00022526362,0.00008501656,0.0007790657,0.00015386927,0.00031831858],"category_scores_gemma":[0.007124142,0.00018937475,0.000116594616,0.0013390337,0.0011976712,0.00010829287,0.00019159929,0.0021087471,0.000032272168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043485854,0.00085701887,0.0041054273,0.0007801943,0.00029241107,0.0005944084,0.003485771,0.001129021,0.94759214,0.0050543747,0.0009130143,0.03084766],"study_design_scores_gemma":[0.0012149398,0.00012908709,0.00017025683,0.00007424531,0.00006399717,0.000010527727,0.0023146996,0.5094787,0.48374823,0.00094316556,0.0015982942,0.00025390778],"about_ca_topic_score_codex":0.000102466765,"about_ca_topic_score_gemma":0.00001556684,"teacher_disagreement_score":0.50834966,"about_ca_system_score_codex":0.00021938756,"about_ca_system_score_gemma":0.0003539981,"threshold_uncertainty_score":0.9161575},"labels":[],"label_agreement":null},{"id":"W4220913938","doi":"10.1055/a-1785-3936","title":"A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies","year":2022,"lang":"en","type":"article","venue":"Drug Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Nasal administration; Medicine; Tuberculosis; Tuberculosis vaccines; Virology; ESAT-6; Adverse effect; Immunology; Influenza vaccine; Equine influenza; Vector (molecular biology); Virus; Mycobacterium tuberculosis; Pharmacology; Biology; Recombinant DNA; Pathology","score_opus":0.24321529921873558,"score_gpt":0.5096641546182696,"score_spread":0.26644885539953406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220913938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86740917,0.046093453,0.000048026282,0.06907957,0.00076623086,0.0053862343,0.000319171,0.00062736974,0.010270766],"genre_scores_gemma":[0.9749139,0.003896553,0.0013846001,0.009046141,0.0017806205,0.0016251805,0.00014579696,0.00024029442,0.0069668894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98917705,0.0020481194,0.0011654632,0.0011544622,0.004492614,0.0019622673],"domain_scores_gemma":[0.9922199,0.0038679242,0.00011834026,0.0013946551,0.0015320498,0.0008670917],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008575843,0.00046678478,0.0011737809,0.0010918513,0.0018947482,0.00008752705,0.00087477197,0.00013481593,0.0015457595],"category_scores_gemma":[0.007596785,0.00040114048,0.00038964942,0.00263167,0.0004942885,0.00018148226,0.002065196,0.00395193,0.00036472618],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024082704,0.0021416454,0.069736265,0.0015884676,0.0038340653,0.0013664853,0.009791266,0.0025441211,0.006856366,0.0010352478,0.82001513,0.05700826],"study_design_scores_gemma":[0.0222048,0.0035891605,0.05217915,0.00064513675,0.0002454505,0.000036089274,0.012008865,0.0022669886,0.0059135114,0.00061385205,0.8992708,0.0010262447],"about_ca_topic_score_codex":0.0007911872,"about_ca_topic_score_gemma":0.0002924121,"teacher_disagreement_score":0.10750475,"about_ca_system_score_codex":0.0017448602,"about_ca_system_score_gemma":0.0024895393,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W4321605991","doi":"10.1055/a-1989-1856","title":"Protein kinases: Role of their dysregulation in carcinogenesis, identification and inhibition","year":2023,"lang":"en","type":"review","venue":"Drug Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"University of Delhi; University Grants Commission","keywords":"Carcinogenesis; Kinase; Identification (biology); Cancer research; Cell biology; Chemistry; Biology; Biochemistry; Gene","score_opus":0.11116995084787305,"score_gpt":0.4048738777376094,"score_spread":0.29370392688973634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321605991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024615353,0.9710896,0.000004049749,0.00008016743,0.00003128368,0.0038569868,0.00007977523,0.00003694558,0.00020582804],"genre_scores_gemma":[0.025244107,0.97240347,0.000013019759,0.0000013092925,0.00008779047,0.0008488828,0.0007863117,0.000082152976,0.00053293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972712,0.0005753349,0.00066164153,0.0004851132,0.0007044738,0.0003022429],"domain_scores_gemma":[0.99875826,0.0001463552,0.00019266043,0.00051765254,0.00029682936,0.00008825226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021225102,0.00019274742,0.0007852258,0.0013802988,0.000056167537,0.000027157252,0.00009797817,0.0002804274,0.000013451633],"category_scores_gemma":[0.00032346958,0.00016912616,0.00014400184,0.0017087976,0.0001763894,0.000055018034,0.00013298167,0.00062053476,0.0000519298],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045405308,0.00011383548,0.000024626326,0.036974765,0.000073830764,0.000039829807,0.0005126391,0.0000018249011,0.019320277,0.0004912442,0.00017463842,0.94222707],"study_design_scores_gemma":[0.0032952228,0.00051416544,0.003526428,0.25313038,0.0008202113,0.00014561582,0.002518971,0.00072549155,0.10308547,0.0054906886,0.62555385,0.0011935116],"about_ca_topic_score_codex":0.00053086836,"about_ca_topic_score_gemma":0.00020613188,"teacher_disagreement_score":0.94103354,"about_ca_system_score_codex":0.00040715688,"about_ca_system_score_gemma":0.0006290145,"threshold_uncertainty_score":0.68967646},"labels":[],"label_agreement":null},{"id":"W4389109367","doi":"10.1055/a-2195-3032","title":"Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Drug Research","topic":"Surgical site infection prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fosfomycin; Medicine; Surgery; Intensive care medicine; Antibiotics; Biology; Microbiology","score_opus":0.36653507043263334,"score_gpt":0.5350459208950055,"score_spread":0.16851085046237213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389109367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000101243595,0.99258935,0.0000035371822,0.00022329322,0.000099488905,0.0061840685,0.0000140041,0.00013363466,0.0007424874],"genre_scores_gemma":[0.000007313059,0.9907006,0.000016210042,0.000034729415,0.00014982893,0.0024044851,0.00031322823,0.00009121058,0.006282389],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99138874,0.0039697783,0.00183847,0.00062022184,0.0013955967,0.0007872077],"domain_scores_gemma":[0.9928646,0.0054410687,0.00031894536,0.0007652097,0.0003266242,0.00028354107],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.013274109,0.00035425174,0.0042770216,0.0015623978,0.00006683068,0.000054758057,0.00025049102,0.00012285466,0.001206638],"category_scores_gemma":[0.010347913,0.0002561602,0.0011489475,0.003447141,0.00008165109,0.000063973326,0.00022740514,0.0018210092,0.0045824326],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007851956,0.0001160897,0.00013048624,0.95478874,0.00006534273,0.00084614265,0.0000067551064,1.6010347e-8,3.331338e-8,0.000018174538,0.0058272756,0.03819309],"study_design_scores_gemma":[0.00013323476,0.000033342043,0.000021393154,0.8821463,0.00039293902,0.0013747093,0.000012186514,0.0000044818817,4.5749616e-8,0.000026028518,0.11571244,0.00014289007],"about_ca_topic_score_codex":0.00012994019,"about_ca_topic_score_gemma":0.000038400693,"teacher_disagreement_score":0.10988517,"about_ca_system_score_codex":0.00078485877,"about_ca_system_score_gemma":0.0006920582,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W4390963814","doi":"10.1055/a-2226-3604","title":"Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study","year":2024,"lang":"en","type":"article","venue":"Drug Research","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Tamsulosin; Placebo; Nightmare; Medicine; Randomized controlled trial; Anesthesia; Internal medicine; Psychiatry","score_opus":0.083464857773017,"score_gpt":0.4232775107857412,"score_spread":0.33981265301272423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390963814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980829,0.0038158058,0.000046955713,0.00038090898,0.00043146484,0.010413849,0.000012114845,0.0001010301,0.003968841],"genre_scores_gemma":[0.9896496,0.00029949637,0.000002876686,0.00003073928,0.000107799526,0.003881551,0.0000029347218,0.00007459378,0.0059504095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9893697,0.004823779,0.00074685167,0.0010904344,0.0027531502,0.0012161207],"domain_scores_gemma":[0.98241186,0.016330235,0.00006096589,0.0007907582,0.00021017574,0.0001959824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009314562,0.00032093114,0.0010558389,0.0016103616,0.00034459186,0.00066884473,0.0011695988,0.00008642892,0.000344197],"category_scores_gemma":[0.0027020676,0.00022669091,0.0002377328,0.0029849485,0.0009863417,0.0003714315,0.0005110524,0.0015067024,0.00030453983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9592825,0.0042910143,0.003773905,0.0006178036,0.00015808646,0.0005963578,0.0035457418,0.000106289095,0.016175663,0.0049804104,0.0003080658,0.0061641666],"study_design_scores_gemma":[0.9185168,0.0015574713,0.000545127,0.00025776992,0.000044487108,0.0000065973345,0.0005640184,0.0092906505,0.065006495,0.0033776618,0.00047713873,0.00035574893],"about_ca_topic_score_codex":0.0018333531,"about_ca_topic_score_gemma":0.0006519156,"teacher_disagreement_score":0.04883083,"about_ca_system_score_codex":0.00016126088,"about_ca_system_score_gemma":0.00036712873,"threshold_uncertainty_score":0.9244187},"labels":[],"label_agreement":null},{"id":"W4416806713","doi":"10.1055/a-2724-6878","title":"Evaluation of the Migrastatic Properties of Selective MMP-2 Inhibitors in Colorectal Cancer: An In Ovo Approach","year":2025,"lang":"en","type":"article","venue":"Drug Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Charotar University of Science and Technology","keywords":"Colorectal cancer; Chorioallantoic membrane; In ovo; Cancer; Pharmacokinetics; Oxaliplatin","score_opus":0.05019395236343698,"score_gpt":0.359873968499927,"score_spread":0.30968001613649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416806713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963998,0.0015975764,0.000004788503,0.0000770074,0.0000388973,0.0008594227,0.0000062960285,0.0000013067562,0.0010148721],"genre_scores_gemma":[0.99947965,0.00004366718,0.000028048818,0.000007766799,0.000023763982,0.000339864,0.000006876737,0.0000058855344,0.00006446438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797237,0.00092946825,0.00019529424,0.00021173315,0.00050774013,0.00018337584],"domain_scores_gemma":[0.9992941,0.000011972313,0.000040142557,0.00016482185,0.0004709702,0.000017992383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002871518,0.000063272644,0.00010927354,0.00016095849,0.000036236885,0.000006116856,0.0001674206,0.00007097609,0.0000024187643],"category_scores_gemma":[0.00038201624,0.000046226603,0.000031104082,0.0005783047,0.00012954218,0.0000057268226,0.000121955214,0.00017683815,1.8431528e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001310974,0.00019312097,0.004872756,0.00006237944,0.000014880659,1.2301541e-7,0.0007502463,0.00025027202,0.9912088,0.00007260394,0.0001648946,0.0022788157],"study_design_scores_gemma":[0.0005145617,0.00009658961,0.0037472663,0.00012721271,0.0000068318277,2.3697164e-7,0.0010676925,0.0035265158,0.9902602,0.0005927428,0.000016129992,0.000044063414],"about_ca_topic_score_codex":0.0018180504,"about_ca_topic_score_gemma":0.0026372618,"teacher_disagreement_score":0.0032762438,"about_ca_system_score_codex":0.00009451229,"about_ca_system_score_gemma":0.00087533874,"threshold_uncertainty_score":0.27483603},"labels":[],"label_agreement":null}]}